Treatment with BAPN disrupts LOX activity, leading to reduced ECM content and tumor stiffness.[6] We observed a significant downregulation of Lox mRNA in tongue tissues of mice in the NA+BAPN group compared to the NA group (Figure 6B). The gene discussed is LOX; the disease is neoplasm.